Literature DB >> 3338720

16,16-Dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver.

M J Ruwart1, B D Rush, K F Snyder, K M Peters, H D Appelman, K S Henley.   

Abstract

Chronic nutritional injury was induced in rats by a high-fat, lipotrope-deficient diet. The hepatoprotective effect of 16,16-dimethyl prostaglandin E2 on the deposition of collagen and fat was assessed by histological evaluation and measurement of hydroxyproline. Dose-response studies established that optimal protection was achieved by the twice daily administration of 16,16-dimethyl prostaglandin E2 at 100 micrograms per kg (subcutaneous) or 250 micrograms per kg (oral). 16,16-Dimethyl prostaglandin E2 and a crystalline analog [(p-acetamidobenzamido)phenyl ester of 16,16-dimethyl prostaglandin E2 significantly delayed both the deposition of collagen and the increase in hepatic hydroxyproline content. There was an excellent correlation between the histological assessment of collagen and the biochemical measurement of hydroxyproline. These data provide a rationale for the evaluation of prostaglandins in the treatment of human liver disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338720     DOI: 10.1002/hep.1840080112

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  A study of the ameliorating effects of carnitine on hepatic steatosis induced by total parenteral nutrition in rats.

Authors:  Li-Jian Liang; Xiao-Yu Yin; Shi-Min Luo; Jin-Fang Zheng; Ming-De Lu; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  Role of prostanoids and nitric oxide inhibition in rats with experimental hepatic fibrosis.

Authors:  M Criado; O Flores; M J Vázquez; A Esteller
Journal:  J Physiol Biochem       Date:  2000-09       Impact factor: 4.158

3.  TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

Authors:  J Muntané; F J Rodríguez; O Segado; A Quintero; J M Lozano; E Siendones; C A Pedraza; M Delgado; F O'Valle; R García; J L Montero; M De La Mata; G Miño
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

4.  Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.

Authors:  Soo Hyun Kim; Gyuri Kim; Dai Hoon Han; Milim Lee; Irene Kim; Bohkyung Kim; Kook Hwan Kim; Young-Mi Song; Jeong Eun Yoo; Hye Jin Wang; Soo Han Bae; Yong-Ho Lee; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Myung-Shik Lee
Journal:  Autophagy       Date:  2017-09-21       Impact factor: 16.016

Review 5.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

6.  Oral diclofenac combined with intra-portal pirarubicin: increased efficacy on liver VX2 tumour and hepatotoxicity in rabbits.

Authors:  B Donatini; C Bognel; J N Munck; L Ramirez; P Ardouin; P Rougier
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 7.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.